BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

AbbVie 



      U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
How Much?! AbbVie (ABBV) Raises Niaspan Price Despite Study Failures 5/24/2013 7:49:00 AM    More...
AbbVie (ABBV) Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients With Diabetic Nephropathy 5/20/2013 10:56:48 AM    More...
AbbVie (ABBV), Galapagos NV (GLPG.BR) Galapagos Ink $50 Million Crohn's Disease Pact 5/17/2013 9:17:50 AM    More...
AbbVie (ABBV) to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting 5/16/2013 7:35:31 AM    More...
Alvine Pharmaceuticals, Inc. Lands $70 Million From AbbVie (ABBV) for Celiac Disease Drug 5/14/2013 10:09:01 AM    More...
AbbVie (ABBV) and Alvine Pharmaceuticals, Inc. to Collaborate on Investigational Oral Therapy for Celiac Disease 5/14/2013 9:50:35 AM    More...
A Culture Change? AbbVie (ABBV) R&D to Retire 5/13/2013 10:12:25 AM    More...
AbbVie (ABBV) to Present at Bank of America (BAC) Merrill Lynch 2013 Health Care Conference 5/7/2013 7:29:14 AM    More...
AbbVie (ABBV)'s Investigational HCV Regimen Receives Breakthrough Therapy Designation From the FDA 5/6/2013 10:10:32 AM    More...
AbbVie (ABBV)'s Investigational HCV Regimen Receives Breakthrough Therapy Designation 5/6/2013 7:45:33 AM    More...
1234